ReferenceRRK5514

IELSG 37

A randomized open label multicentre two-arm phase III comparative study assessing the role of mediastinal radiotherapy after rituximab containing chemotherapy regimens to patients with newly diagnosed Primary Mediastinal Large B-cell Lymphoma (PMLBCL)

Research Summary

Research Overview
PI Name Zarkar - A
Speciality
Project Status Open
Proposed End Date 27/10/2016
Study Run through CRF? No
Recruitment so far 0